Cancer Prevention in Inflammatory Bowel Disease and the Chemoprophylactic Potential of 5-Aminosalicylic Acid

This publication has 45 references indexed in Scilit:

• 5-aminosalicylic acid (5-ASA) but not acetylsalicylic acid (aspirin) reduces the spontaneous mutation rate at a (CA)13 microsatellite (MS)
  Gastroenterology, 2001
• Mesalazine Changes Apoptosis and Proliferation in Normal Mucosa of Patients with Sporadic Polyps of the Large Bowel
  Endoscopy, 2000
• Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire
  European Journal of Gastroenterology & Hepatology, 1996
• Colorectal Adenocarcinoma in Crohn's Disease
  Annals of Surgery, 1996
• Estrogen Replacement Therapy and Risk of Fatal Colon Cancer in a Prospective Cohort of Postmenopausal Women
  JNCI Journal of the National Cancer Institute, 1995
• Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis.
  Gut, 1994
• Differences in NSAID Tolerability Profiles
  Drug Safety, 1994
• Reduced Risk of Large-Bowel Adenomas Among Aspirin Users
  JNCI Journal of the National Cancer Institute, 1993
• Increased risk of large-bowel cancer in Crohn's disease with colonic involvement
  The Lancet, 1990
• Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years.
  Gut, 1990